Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) MAML1 Antibodies:
anti-Rat (Rattus) MAML1 Antibodies:
anti-Human MAML1 Antibodies:
Go to our pre-filtered search.
Human Polyclonal MAML1 Primary Antibody for EIA, FACS - ABIN953326
Lindberg, Popko-Scibor, Hansson, Wallberg: SUMO modification regulates the transcriptional activity of MAML1. in FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2010
Show all 5 references for ABIN953326
Human Polyclonal MAML1 Primary Antibody for IHC, ELISA - ABIN185074
Wu, Aster, Blacklow, Lake, Artavanis-Tsakonas, Griffin: MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors. in Nature genetics 2000
Human Polyclonal MAML1 Primary Antibody for FACS, WB - ABIN655505
Hao, Rizzo, Osipo, Pannuti, Wyatt, Cheung, Sonenshein, Osborne, Miele: Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells. in Oncogene 2010
BCL6 (show BCL6 Antibodies) inhibits transcription by competing for the Notch1 (show NOTCH1 Antibodies) intracellular domain, preventing the coactivator Mastermind-like1 (MAM1) from binding.
XMam1 has the ability to induce the cell fate into the neurogenic lineage in a Notch (show NOTCH1 Antibodies)-independent manner
These observations suggest that chondrocyte maturation was impaired in MAML1(-/-) mice. MAML1 enhances the transcriptional activity of Runx2 (show RUNX2 Antibodies) and plays a role in bone development.
This study demonstrated that targeting Maml1-induced tumor cell senescence and differentiation may alter the tumor microenvironment and cytokine and chemokine (show CCL1 Antibodies) profiles and may also promote innate and adaptive immune cell infiltration and function.
Maml-mediated Notch (show NOTCH1 Antibodies) signaling plays a pivotal role in the initiation and maintenance of goblet cell differentiation for normal ocular surface morphogenesis.
Mastermind-like 1 (MamL1) and mastermind-like 3 (MamL3 (show MAML3 Antibodies)) are essential for Notch (show NOTCH1 Antibodies) signaling in vivo.
Data demonstrate that Mesp2 (show Mesp2 Antibodies) potently represses Notch (show NOTCH1 Antibodies) signaling by inducing the destabilization of mastermind-like 1, a core regulator of this pathway.
MAML1 is a novel modulator for NF-kappaB (show NFKB1 Antibodies) signaling and regulates cellular survival.
There seems to be close correlation of the spatial and temporal expression of Maml1, in the central nervous system (CNS) during early development, implicating a role for the Maml1 gene in neurogenesis.
a dominant negative mutant of MAML1 resulted in early inhibition of T-cell development and the appearance of intrathymic B cells, phenotypes consistent with Notch1 (show NOTCH1 Antibodies) inhibition
MAML1 acts as a coactivator for MEF2C (show MEF2C Antibodies) transcription and is essential for proper muscle development
Mam-1 is required to some extent for Notch (show NOTCH1 Antibodies)-dependent stages in lymphopoiesis, thus supporting the notion that Mam (show ATF7IP Antibodies) is an essential component of the canonical Notch (show NOTCH1 Antibodies) pathway in mammals.
study identifies that MAML1 is ubiquitinated in the absence of Notch (show NOTCH1 Antibodies) signaling to maintain low levels of MAML1 in the cell
In MCF-7 cells p53 (show TP53 Antibodies) associates with the Notch (show NOTCH1 Antibodies) transcriptional complex (NTC) in a MAML1-dependent fashion, most likely through a p53 (show TP53 Antibodies)-MAML1 interaction.
The impact of MAML1 genetic variants to heart rate was discovered.
Data indicate that EpCAM (show EPCAM Antibodies), CK19 (show KRT19 Antibodies), and hMAM triple-marker-positive circulating tumor cells (CTCs) were detected in 86 of 98 (87.8 %) patients.
Snail (show SNAI1 Antibodies) decreased transcription of Notch1 (show NOTCH1 Antibodies) intracellular domain (NICD (show NOTCH1 Antibodies)) target genes via competing with MAML1, co-activator, in NICD (show NOTCH1 Antibodies) complex.
Authors report that human papillomavirus type 8 E6 subverts NOTCH (show NOTCH1 Antibodies) activation during keratinocyte differentiation by inhibiting RBPJ (show RBPJ Antibodies)/MAML1 transcriptional activator complexes at NOTCH (show NOTCH1 Antibodies) target DNA.
Bioinformatics assessment revealed a correlation between p300 (show EP300 Antibodies), EGR1 (show EGR1 Antibodies) and MAML1 copy number and mRNA alterations in renal clear cell carcinoma and p300 (show EP300 Antibodies), EGR1 (show EGR1 Antibodies) and MAML1 gene alterations were associated with increased overall survival.
MAML1 is best known as the co-activator and effector of NOTCH (show NOTCH1 Antibodies)-induced transcription, and BPV-1 E6 represses synthetic NOTCH (show NOTCH1 Antibodies)-responsive promoters, endogenous NOTCH (show NOTCH1 Antibodies)-responsive promoters, and is found in a complex with MAML1 in stably transformed cells
Overexpression of MAML-1 and Twist1 (show TWIST1 Antibodies) were significantly associated with lymph node metastasis and the surgical staging of tumor
This protein is the human homolog of mastermind, a Drosophila protein that plays a role in the Notch signaling pathway involved in cell-fate determination. There is in vitro evidence that the human homolog forms a complex with the intracellular portion of human Notch receptors and can increase expression of a Notch-induced gene. This evidence supports its proposed function as a transcriptional co-activator in the Notch signaling pathway.
, mastermind-like 1
, mastermind-like protein 1
, mastermind homolog